TP53 and cancer: In addition, since aspirin effects on NFκB and apoptosis occur in cancers arising from different genetic backgrounds, these findings are clinically relevant when considering design of chemoprevention trials, both in genetically predisposed individuals with defective MMR and in low and moderate risk populations, since p53 mutational events are important during development and progression of colorectal neoplasia.